[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. You can find his bio and his past articles on his Stock Gumshoe page.] “The universe (which others call the Library) is composed of an indefinite and […]
4,732 Comments Read MoreArticles
Oncotutorial
The “Curing Cancer Portfolio” (Part One)
“Breakthrough ‘Magic Bullet’ Technology Crushes Cancer Tumors Within 36 Hours…”
Bob Czeschin’s Oil Antidote to Al Qaeda
Before I get started today with our Friday File I do want to do a couple things: First, to thank you for your continuing patience as we try to fix lingering technical problems after our site was taken down by attack two weeks ago. None of our data has been compromised, but a small percentage […]
2 Comments Read MoreCan Bill Gates Cure Cancer?
Just a quick note to update you on a teaser that I wrote about a little while ago … it’s being repeated again. This time, the email is going out from a different part of the Lynn Carpenter empire, as part of the Total Health Breakthroughs email newsletter … and they’d still like you to […]
9 Comments Read More“Baker Brothers Biotech Baby Blue-Chip”
This one comes in a teaser ad for the Rising Tide Letter from Lynn Carpenter, which I’ve never looked at before. Aside from some fabulous alliteration, it offers a biotech stock that’s been picked by some high-profile biotech investors … a pick that Lynn apparently believes is a blue chip in the making. Trying the […]
15 Comments Read MoreWe use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
$CASC $SGEN“Seattle Genetics disappoints Puma bulls with Cascadian takeout” Date January 31, 2018Why buy Pu...
$CASC, long - Seattle Genetics (NASDAQ:SGEN) has agreed to acquire Cascadian Therapeutics (NYSE:CASC) for $10 per share ...
Gotta tell you....this company has a long way to go. And competes with outfits like Seattle Genetics. And will in future...
$DR The undertow over at $IMMU has finally shifted, up 16% this week, Doc said back in 2014 it looked fairly solid. Som...
la storm...you did a great job...read through a lot of what you presented...concerned about the head medical scientist l...
Look out Seattle Genetics: Mersana Therapeutics is coming to IPO. We've had our eye on Mersana for a time. It's from the...
Good lord, as a shareholder I'd be quite happy settling for another Seattle Genetics. But if they're aiming higher, god...
Hi all: I am far behind on reading posts because of obligations and things that have come up today. Will catch up.I ...
Hi geoffbPieris' anticalins are amazingly versatile. They can be stuck onto an antibody, or stuck onto just the FC ...
$INCYIncyte Corporation (INCY) a likely takeover target for Gilead Sciences, Inc. (GILD) Published By News Desk ...
$SGENSeattle Genetics Announces Clinical Hold on Several Phase 1 Trials of Vadastuximab Talirine (SGN-CD33A). Fatali...
BTX is up some -Also Seattle Genetics ?...
A report in WSJ this morning notes that the BAker Bros of biotech investing have retrenched their positions in Seattle G...
Analyst Ratings $RLYP, $TRVN, et al - April 17th - From News on The Street: "Analysts Offer Insights on Healthcare Comp...
$SGEN- FELIX BAKER Buys $22,551,290 Worth of $SGEN Seattle Genetics, Inc. - #Form4 #InsiderTrading - http://investor.sea...
Sorrento Therapeutics (SRNE) and NantKwest (NK) — BioPortfolio.com"...Sorrento owns about 3.03M shares of NantKwe...
This deal with Seattle Genetics (SGEN) taking with Unum Therapeutics may pay off for them down the road. The founder and...
$SGEN = Seattle Genetics - trading near its lows for the last 12 months with earnings to be reported on 2/10. Any fresh...
Sorry if this is a repost. Big news for Seattle Genetics $SGEN today (my newest long biotech position) Seattle Gene...
initiated a small speculative position in Seattle Genetics (SGEN) this morning. If Baker Brothers likes these prices, t...
Great memory, Doc. An Oct 2014 CNBC report briefly talks about "a salacious Wall Street child custody and divorce battl...
$SGEN, $AGIO Seattle Genetics Inc. (NASDAQ: SGEN) shows up on our screens for the second time this month, and for the s...
Ken, Immunogen $IMGN has been solidly trounced over the last year. It can go lower. It is a complex company that has a l...
Eyedoc, I posted something on $SGEN and got a weird error message, so am not sure it uploaded. Seattle Genetics has a gr...
Hi Gang, Bought some Seattle Genetics (SGEN) today. Loads of heavy recent insider buying by the famous Baker brothers ...
Gary: Thanks for posting and I appreciate your comments. Alnylam certainly has a future, though by now it is big. I don'...
And Catawba, you've got a ticker typo -- this is SGEN (Seattle Genetics) not ZGEN (ZymoGenetics). SGEN hasn't had any i...